The global burden of fungal infections is rising at an alarming rate, with superficial, cutaneous, and mucosal mycoses among the most prevalent. Conventional treatments rely on oral and topical antifungal agents; however, these therapies are often limited by adverse effects, toxicity, frequent recurrence, and poor patient adherence due to prolonged treatment regimens. Moreover, the emergence of antifungal resistance and multidrug-resistant species such as Candidozyma auris and Trichophyton indotineae highlights the urgent need for alternative therapeutic strategies, such as antimicrobial photodynamic therapy (aPDT). aPDT is based on photophysical and photochemical processes involving a photosensitizer (PS), a light source, and molecular oxygen. When combined, these elements generate reactive oxygen species that selectively destroy microbial cells. In this review, we explore various PSs and their effectiveness in aPDT against infections caused by dermatophytes, Candida spp., and other pathogenic fungi. Promisingly, aPDT has demonstrated antifungal activity against both susceptible and resistant strains. In addition, aPDT has been successfully used in cases of mycoses unresponsive to conventional therapies, showing favorable clinical outcomes and overall safety. Current evidence supports aPDT as a valuable strategy for the management of cutaneous, mucosal, and superficial fungal infections and as a potential strategy to combat antifungal resistance.

Staphylococcus aureus is a major pathogen responsible for both clinical and subclinical bovine mastitis. Its ability to persist within the mammary gland and evade host immune responses makes it particularly significant for herd health and dairy production. So, this study aimed to evaluate whether the presence and diversity of S. aureus virulence genes mastitis-causing are associated with the onset and severity of mastitis in dairy cows. We analyzed 50 S. aureus isolates obtained from milk samples of cows with subclinical mastitis (SM) and 101 isolates from clinical mastitis (CM), including 28 from mild and 73 from moderate cases. These isolates were screened for genes encoding enterotoxins (sea, seb, sec, sed, see, seg, seh, sei, and sej), biofilm production (bap, icaA, and icaD), toxic shock syndrome toxin (tsst-1), Panton-Valentine leukocidin (pvl), and microbial surface components recognizing adhesive matrix molecules (fnbA, fnbB, fib, clfA, clfB, cna, eno, and ebpS). In addition, pulsed-field gel electrophoresis (PFGE) was used to differentiate the genetic profiles associated with the various disease presentations. The CM isolates presented 16 out of 22 (72.7%) virulence genes compared with 14 (63.6%) in SM isolates. Regardless of mastitis severity, icaD (99.3%), eno (98%), and clfA (78.8%) were the most frequently observed, and seb and sej were not found. Our results also revealed that the virulence genes significantly associated with CM were fnbA, fib, clfA, clfB, cna, ebpS, seg, seh, sei, bap, and icaA. The PFGE revealed that no single cluster included isolates causing both CM and SM. However, CM clusters contained isolates from both mild and moderate mastitis cases. Although the host is a significant variable in the development of mastitis, our findings demonstrate that the virulence profile can play a crucial role in disease progression, as further supported by PFGE results, which showed a distinct separation between CM and SM clusters.

Larvae of the greater wax moth Galleria mellonella have become an increasingly important in vivo model for biomedical research, providing a practical, ethical, and biologically relevant alternative to vertebrate organisms. Its suitability as a model system lies in its low maintenance cost, ease of handling, and ability to survive at both ambient and mammalian body temperatures. Most importantly, G. mellonella exhibits an innate immune system with functional and structural parallels to that of mammals, allowing meaningful insights into infection dynamics and immune responses. This review summarizes the biological and immunological foundations that underpin the use of G. mellonella in experimental research and examines its expanding range of applications. The model has been successfully employed to study microbial pathogenicity, antimicrobial efficacy, host–pathogen interactions, and toxicological responses. In recent years, its use has extended to emerging fields such as nanomedicine, immunomodulation, and environmental biotechnology, reflecting its growing translational value. The adoption of G. mellonella also aligns with current ethical principles in science, particularly the 3Rs framework (replacement, refinement, and reduction), by minimizing the use of vertebrate animals while maintaining robust experimental outcomes. However, certain challenges persist, including the lack of adaptive immunity and the need for methodological standardization to enhance data reproducibility and comparability across laboratories. Collectively, the growing body of evidence supports G. mellonella as a reliable and versatile experimental model that bridges the gap between invertebrate and mammalian systems. Continued methodological refinement and integration with molecular and omics approaches are expected to further consolidate its role in translational and preclinical research. © 2026 The Author(s). Current Protocols published by Wiley Periodicals LLC.

Dermatophytosis is a cutaneous mycosis caused by keratinolytic fungi, classified as dermatophytes, affecting 20–25% of the global population and representing a significant public health concern. The disease manifests as circular, erythematous, pruritic, and desquamative skin lesions, hair breakage and loss, and nail degradation, leading to considerable morbidity. In addition, dermatophytosis can markedly impair patients’ quality of life. Despite the high global prevalence of dermatophytosis, the causative agents are often misdiagnosed, and there is limited data on the epidemiology and genomic surveillance of dermatophytosis worldwide. This review aims to update the global epidemiology of dermatophytosis and dermatophytes while addressing their taxonomy, pathogenesis, virulence factors, clinical manifestations, and antifungal therapy. Consistently, Trichophyton spp., particularly T. rubrum, T. mentagrophytes, and T. interdigitale, remain the predominant pathogens worldwide. Recently, T. indotineae has gained prominence due to its global dissemination, significant terbinafine resistance, extensive lesions, therapeutic failure, and recurrence. Furthermore, studies have reported endogenous cases of T. indotineae infections in Asia and Europe, and exogenous reports in the Americas and Oceania. Among non-Trichophyton dermatophytes, Microsporum canis and M. audouinii stand out as relevant pathogens, particularly in endemic regions and specific clinical settings, such as scalp infections. Overall, these factors emphasize the importance of global vigilance regarding dermatophyte dissemination. This review also highlights a discrepancy between accurate fungal identification and global reporting, raising concerns regarding epidemiological surveillance and underscoring the need for improved strategies to manage dermatophytosis worldwide.